A new drug, recognised by the Food and Drug Administration (FDA) as being intended to treat a serious or life-threatening disease, for which preliminary clinical evidence suggests a substantial improvement over existing therapies. Breakthrough therapy designation is intended to expedite the development and review of drugs for serious or life-threatening conditions.
Menu